Obesity Treatment: Your Guide to Safe and Effective Options

Obesity Treatment: What Really Works

Obesity Treatment: What Really Works
Everyday Health
Obesity is a growing health concern, affecting more than 100 million adults in the United States alone, and its treatment options have evolved dramatically in recent years.

Medications like GLP-1 agonists, as well as minimally invasive bariatric surgeries, offer lasting results with few complications.

At the same time, healthy eating and regular physical activity remain the foundations of managing and treating obesity and associated conditions.

Please also note that it’s important to discuss any of the following options with a healthcare practitioner before you start treatment. Read on to learn about obesity treatment, including more on medications, surgical options, and lifestyle changes that can help.

Medication

Lifestyle changes like healthy eating and exercise will always be the first-line treatment for overweight and obesity. Medications for obesity are also getting safer and more effective every year.

Your doctor will likely consider factors such as your medical history, any other medications you are taking, and your BMI before prescribing a particular drug. They may also consider the cost, the amount of weight loss required, potential side effects, and the impact it may have. Here are some of your options for obesity treatment medications.

GLP-1 Agonists

In recent years, glucagon-like peptide1 (GLP-1) agonists have become more popular as a treatment for obesity.

 Blood-sugar-lowering GLP-1 agonists were initially developed as a drug for type 2 diabetes, but some of them are effective in treating obesity as well.

 Studies suggest that people who take GLP-1 agonists or dual agonists can lose between 8 and 22 percent of their body weight on average after about one year.

GLP-1 agonists work by mimicking the effects of the hormone glucagon-like peptide-1, which your intestines release in response to eating. Glucagon and GLP-1 both signal to your brain that you’ve eaten enough, causing a feeling of fullness. They also slow down your gastrointestinal tract, causing food to stay in your stomach longer, which means you feel full for longer and are less likely to overeat.

The U.S. Food and Drug Administration (FDA) has approved two GLP-1 agonists for weight loss:

  • liraglutide (Saxenda)
  • semaglutide (Wegovy)
A third approved drug, tirzepatide (Zepbound), is in a similar class. It’s a GLP-1 agonist that also binds to glucose-dependent insulinotropic polypeptide (GIP) receptors and helps your body make insulin.

Saxenda is injected daily, whereas Wegovy (injection) and Zepbound are injected weekly. Wegovy is also now available as an oral tablet taken once daily. Side effects for these medications can include the following:

  • Bloating
  • Fatigue
  • Gas
  • Headache
  • Heartburn
  • Nausea or vomiting
  • Diarrhea or constipation
With Wegovy, there are concerns about rare but serious complications, such as thyroid tumors and pancreatitis.

Phentermine

Phentermine is an oral appetite suppressant that’s often combined with the anti-epileptic drug topiramate. The combination of phentermine and topiramate is known as Qsymia; it is approved by the FDA for long-term use and recently became available in a generic form.

Phentermine makes your body release the neurotransmitter norepinephrine, which reduces the sensation of hunger.

Common side effects can include the following:

  • Faster heart rate or elevated blood pressure
  • Sleeplessness
  • Nervousness
  • Constipation
Phentermine and topiramate can also increase blood pressure and heart rate, so these need to be monitored. Topiramate can cause serious birth defects

 and needs to be accompanied by highly reliable birth control in women of childbearing age.
Phentermine alone is not approved for long-term use, but it is typically used long term if an obesity medicine specialist determines that the patient is having a good weight-loss response. Qsymia is FDA-approved for long-term use.

Bupropion-Naltrexone

Bupropion-naltrexone (Contrave) is a combination drug used for weight loss. Bupropion works in the brain to reduce appetite and is also commonly used to treat depression (it is used to help people quit smoking, too). Naltrexone is an FDA-approved treatment for alcohol and opiate addiction, and in general, it should only be used for weight control in combination with bupropion.

Common side effects of Contrave include nausea, dizziness, and changes in bowel habits (diarrhea and constipation).

Bupropion can increase blood pressure and heart rate. You should not take Contrave if you have a seizure disorder, if you take opiate pain medicines, if you have an active eating disorder, or if you have advanced kidney or liver disease. Contrave is FDA-approved for long-term use.

Orlistat

Orlistat, helps your body absorb less fat by blocking the enzyme intestinal lipase, which breaks down fat.

Orlistat is sold as a prescription under the brand name Xenical, but there is a lower-dose, over-the-counter version called Alli. Both come as oral pills. For best results, you should make sure less than 30 percent of the total calories you eat in a day come from fat.

When you take orlistat, the fat that your body didn’t absorb is excreted with your feces. That means a lot of orlistat’s side effects are bowel related:

  • Bowel incontinence and an urgent need to go
  • Diarrhea or loose stool
  • Headache
  • Oily or fatty stool
  • Oily spotting in your underwear or when you pass gas
  • Stomach pain
While orlistat blocks your body's ability to absorb fat, it also hinders your body’s ability to absorb certain vitamins. Your healthcare provider will probably recommend a multivitamin.

Bariatric Surgery

Bariatric surgery refers to a group of surgical procedures designed to help people with obesity lose weight. Bariatric surgeries are sometimes called weight-loss surgeries. Healthcare professionals tend only to suggest bariatric surgery as an option if other methods of weight loss have been unsuccessful.

Candidates for bariatric surgery generally either have a BMI of 40 kg/m2 or over, or a BMI of 35 to 39.9 kg/m2, plus an obesity-related condition like diabetes or heart disease. Most types of bariatric surgery can be performed laparoscopically, which is a minimally invasive technique using smaller incisions and smaller tools than traditional open surgery. This may cut down on the rate of post-op complications and shorten recovery time.

Weight loss surgery isn’t for everyone, and it’s important to discuss the possible risks with your doctor. Your insurance company may have specific requirements, such as proof of trying other methods first. Continued weight loss — and eventually maintenance — may be achieved when surgery is combined with diet and lifestyle changes.

Here are some of your surgical obesity treatment options.

Sleeve Gastrectomy

According to the American Society for Metabolic and Bariatric Surgery, sleeve gastrectomy is the most popular type of bariatric surgery by far, with more than 157,000 procedures performed in 2023.

With a sleeve gastrectomy, a surgeon will remove approximately 80 percent of your stomach. What’s left over is roughly the size and shape of a banana.

 Not only can your stomach now hold less food, which makes you less likely to overeat, but the portion removed also makes the majority of ghrelin. Ghrelin is a hormone that signals to your brain that your body needs food.

After five years, you can expect to have lost up to 60 percent of your excess weight (approximately 20 percent of your starting body weight). Short-term complication rates are generally low but can include surgical site infection, leakage, and internal bleeding. Common long-term complications include nutritional deficiencies, weight regain, and a roughly 25 percent risk of worsening of heartburn.

Some centers are now performing sleeve gastrectomy endoscopically (through a scope, rather than with incisions). This procedure leads to weight loss that is somewhat less than with surgical sleeve gastrectomy (approximately 10-15 percent of starting body weight after five years). But most insurance plans do not cover endoscopic sleeve gastrectomy.

Roux-en-Y Gastric Bypass

Gastric bypass (also known by the French phrase Roux-en-Y) is the second most popular form of bariatric surgery.

This operation reduces the size of your stomach (even smaller than a sleeve gastrectomy) and reroutes your gastrointestinal tract to skip most of the stomach and the first half of the small intestine. This means that fewer calories are both consumed and absorbed.

You can lose 70 percent or more of your excess weight within two years of gastric bypass (approximately 25 percent of starting body weight). Complications mirror those of sleeve gastrectomy, with the addition of possible long-term risk of bowel obstruction dumping syndrome (when food moves too quickly through your GI tract), hypoglycemia after gastric bypass, and less commonly, internal hernia. The risk of alcohol use disorder also seems to be higher after gastric bypass. Risk of nutritional deficiencies is also higher after gastric bypass.

Biliopancreatic Diversion With Duodenal Shift (BPD-DS)

BPD-DS is a more aggressive procedure in which a sleeve gastrectomy is combined with a more extensive bypass of the small intestine. It is sometimes done in one operation and sometimes done in two separate operations. It carries a higher risk of nutrient malabsorption because of the longer bypass in the small intestine. It produces the largest weight loss on average but also comes with the highest risk of nutrient deficiency.

Because of its technical difficulty, BPD-DS is performed in fewer centers than sleeve gastrectomy or gastric bypass. It’s usually reserved for people with very high BMI. Surgical complications are similar in rate and nature to gastric bypass.

Gastric Balloon

The gastric balloon is one option for people needing to lose weight before they can safely undergo a permanent bariatric procedure (sleeve, bypass, or BPD-DS). A surgeon uses a long, flexible tool called an endoscope to place a balloon into your stomach, which is then filled with saline or air. It takes up room in your stomach, which keeps you from eating too much. After you’ve lost some weight, you have the balloon removed. The balloon is not a long-term solution for obesity treatment because it has to be removed. It should be viewed as a step toward another treatment modality (medication or surgery).

Complications are generally mild, and may include nausea, stomach pain, constipation, and acid reflux. A gastric balloon is generally not covered by insurance.

Diet and Lifestyle Changes

Eating less and moving more is Weight Loss 101, says Dr. Webb. “Everyone should start with lifestyle modifications: diet and exercise.” But, he cautions, “90 percent of weight loss is diet and only 10 percent is exercise.”

Your healthcare team might want to see what progress you can make for at least six months before you think about medication or surgery. If you haven’t lost at least 5 percent of your starting weight, says Webb, most providers will start thinking about adding medication or weight loss surgery.

Changing your eating patterns is easier said than done. Webb has tips.

  • Mind your snacks. “Dieting starts at the grocery store,” he says. “If the junk gets home, you’ll eat it, so it’s best to just leave it at the store. If the only snacks at home are grapes, strawberries, and peaches, that’s what you’re going to snack on.”
  • Think of your least favorite vegetable, then search Google Images along with the term “recipes.” “There’s always one that [my patients] find that looks good and they’re willing to try based on the image,” says Webb.
  • Start exercising with 30 minutes of walking. “My patients who do this start to lose weight and are amazed that the pain in their knees, back, hips, feet, and other joints is less, they have more energy, and they’re sleeping better. Overall they feel better,” says Webb.
The following strategies may help with obesity:

  • Reduce your daily calorie intake gradually.
  • Consider adding more plants to your diet.
  • Gradually add physical activity that you enjoy to your daily life, and ask your doctor how to safely begin an exercise program.

“I have my patients set a [weight loss] goal of one pound a week,” says Webb. That means eating 500 fewer calories than you burn every day. “That is safe, sustainable weight loss,” he says. Starting small — say, a nightly 30-minute walk and substituting veggies for pasta — can lead to that 500-calorie deficit, says Webb.

Complementary and Integrative Approaches

According to research, there’s no evidence that any supplements can help you lose weight or treat obesity.

 But the following complementary approaches may help with other obesity treatments by increasing self-awareness:
  • Meditation
  • Mindful eating
  • Yoga
Another area of interest is the practice of acupuncture. In one review, the combination of electroacupuncture and usual care was found to significantly reduce body weight and BMI in participants compared with usual care alone.

“Any complementary treatment that the patient is willing to stick with is helpful,” says Webb. “The ones I have found to be most helpful in my patient population have been hypnosis, acupuncture, and yoga.”

Remember, “complementary” is the important part. All these therapies work best when combined with proven treatments.

The Takeaway

  • GLP-1 agonists, like Saxenda and Wegovy, are popular weight loss drugs, with potential weight loss of up to 15 percent, though they have side effects and risks such as nausea and pancreatitis.
  • Bariatric surgery options, including sleeve gastrectomy, gastric bypass, and gastric balloon, offer effective long-term weight loss but come with risks and require a commitment to lifestyle changes post-surgery.
  • Lifestyle changes, especially dietary adjustments and exercise, are key to weight loss success. Try gradual calorie reduction, a largely plant-based diet, and consistent physical activity alongside other treatment methods for best results.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Adult Obesity Facts. Centers for Disease Control and Prevention. May 14, 2024.
  2. Han SH et al. Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis. Aesthetic Surgery Journal. January 2024.
  3. GLP-1 Agonists. Cleveland Clinic. July 3, 2023.
  4. Reiss AB et al. Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss. Biomolecules. March 13, 2025.
  5. Collins L et al. Glucagon-Like Peptide-1 Receptor Agonists. StatPearls. February 29, 2024.
  6. Farzam K et al. Tirzepatide. StatPearls. February 20, 2024.
  7. Tirzepatide Injection. Cleveland Clinic.
  8. Top Weight Loss Medications. Obesity Medicine Association. July 29, 2025.
  9. FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight. U.S. Food and Drug Administration. March 8, 2024.
  10. Phentermine. National Center for Biotechnology Information. January 10, 2026.
  11. Is Phentermine a Good Choice for Weight Loss? Mayo Clinic. October 10, 2025.
  12. Safety Information. Qsymia.
  13. Lazarus E. Appropriate Use of the Fixed-Dose, Extended-Release Combination of Naltrexone and Bupropion as Treatment for Obesity in Primary Care. Obesity Pillars. February 26, 2025.
  14. Contrave. Drugs.com. April 24, 2025.
  15. Bansal AB et al. Orlistat. StatPearls. February 14, 2024.
  16. Orlistat. MedlinePlus. July 20, 2024.
  17. Estimate of Bariatric Surgery Numbers, 2011-2023. American Society for Metabolic and Bariatric Surgery.
  18. Sleeve Gastrectomy. Mayo Clinic. August 2, 2024.
  19. Obesity. Mayo Clinic. December 2, 2025.
  20. Herbal remedies and supplements for weight loss. MedlinePlus. July 3, 2025.
  21. Kim Y et al. Effectiveness and Safety of Acupuncture Modalities for Overweight and Obesity Treatment: A Systematic Review and Network Meta-Analysis of RCTs. Frontiers in Medicine. August 20, 2024.

Adam Gilden, MD, MSCE

Medical Reviewer

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight Management and Wellness Clinic in Aurora. Dr. Gilden works in a multidisciplinary academic center with other physicians, nurse practitioners, registered dietitians, and a psychologist, and collaborates closely with bariatric surgeons.

Gilden is very involved in education in obesity medicine, lecturing in one of the obesity medicine board review courses and serving as the lead author on the Annals of Internal Medicine article "In the Clinic" on obesity.

He lives in Denver, where he enjoys spending time with family, and playing tennis.

Patrick-Sullivan-bio

Patrick Sullivan

Author
Patrick Sullivan has been a writer and editor since 2009 and working exclusively with healthcare publications, practices, and brands since 2015. He is the former executive editor of SpineUniverse.com and has written for HealthCentral, diaTribe.org, and many others.

A New Jersey native, Patrick is a father of two children and servant to an ever-changing number of pet rabbits.